Mapping the regulatory landscape of AI in healthcare in Africa
Frontiers in Pharmacology · 24.08.2023 · 14
DOI: 10.3389/fphar.2023.1214422 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.08.2023. Verfasst von Beverley Alice Townsend und 5 weiteren Autor:innen. Beteiligte Einrichtung: York Law School, University of York, York, United Kingdom. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, UK Research and Innovation.
Abstract (Originalsprache)
Introduction
Artificial intelligence (AI)-enhanced technology has seen unprecedented expansion in the recent past. This growth brings with it huge opportunities for the positive transformation of the economy, business, healthcare, and society. However, a critical question is whether, and to what extent, regulatory measures and mechanisms have been implemented to safeguard its design, development, and deployment. This paper offers a scoping exercise that maps the regulatory landscape of AI in healthcare (including health research) in certain African countries.
Methods
This research is conducted across 12 African countries: Botswana, Cameroon, The Gambia, Ghana, Kenya, Malawi, Nigeria, Rwanda, South Africa, Tanzania, Uganda, and Zimbabwe. As limited specific AI legislation is found in these African countries, and because AI is informed by ancillary regulatory frameworks, we include data protection, digital health, consumer protection, and intellectual property in our research. A scoping review method was applied with a manual search of digital libraries with search terms customised for each repository consisting of core search terms for the various topics, including, among others, “law,” “regulation,” “artificial intelligence,” “data protection,” “intellectual property,” and “digital health”. Results and discussion: Analysis of the data demonstrated that while in the African countries under investigation there is no sui generis AI regulation, recent developments were found in areas that inform AI adoption, including in digital health, data protection, consumer protection, and intellectual property. Our findings highlight the fragmentation of the African AI regulatory landscape and illustrate the importance of continued AI regulatory development to ensure that Africa is well positioned for future AI adoption in health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- York Law School, University of York, York, United Kingdom.
- School of Law, University of KwaZulu-Natal, Durban, South Africa.
Förderung
- National Institutes of Health
- UK Research and Innovation
Zitieren
APA
Townsend, B. A., Sihlahla, I., Naidoo, M., Naidoo, S., Donnelly, D. L., & Thaldar, D. W. (2023). Mapping the regulatory landscape of AI in healthcare in Africa. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1214422
Vancouver
Townsend BA, Sihlahla I, Naidoo M, Naidoo S, Donnelly DL, Thaldar DW. Mapping the regulatory landscape of AI in healthcare in Africa. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1214422
BibTeX
@article{Townsend2023,
author = {Townsend, Beverley Alice and Sihlahla, Irvine and Naidoo, Meshandren and Naidoo, Shiniel and Donnelly, Dusty-Lee and Thaldar, Donrich Willem},
title = {Mapping the regulatory landscape of AI in healthcare in Africa},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1214422}
}
EUVIMED